Palbace 125 mg Capsule

Product Description

Palbace 100 mg capsules are a targeted anticancer treatment containing the active ingredient palbociclib, specifically designed for adults battling hormone receptor-positive (HR+) breast cancer that has metastasized to other areas of the body. This medication is often prescribed in conjunction with an aromatase inhibitor as an initial hormonal therapy or alongside fulvestrant for patients whose cancer has advanced despite prior hormonal treatment. Palbociclib works by inhibiting specific proteins that promote cancer cell growth, thereby slowing the progression of the disease. It's crucial for patients to be monitored for potential side effects, including low blood cell counts, which may increase the risk of infections or bleeding. Patients should also inform their healthcare provider of any existing liver issues or other medications they are taking to avoid harmful interactions. By choosing Palbace, patients take an important step in their treatment journey against advanced HR+ breast cancer, benefiting from its precise mechanism of action. Always consult your oncologist to discuss the best treatment plan tailored to your individual needs.